Showing results (21-30 of 1,105) with videos related to
Sort By:
Pageof 111
The Journal of Experimental Medicine|March 1, 1985
Bone marrow graft rejection as a function of antibody-directed natural killer cellsJ F Warner, G DennertJournal of Immunology (Baltimore, Md. : 1950)|August 15, 1988
Transmembrane chloride flux is required for target cell lysis but not for Golgi reorientation in cloned cytolytic effector cells. Golgi reorientation, N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase release, and delivery of the lethal hit are separable events in target cell lysisG Prochazka, C Landon, G DennertJournal of Immunology (Baltimore, Md. : 1950)|August 1, 1988
Cell-mediated and glucocorticoid-mediated target cell lysis do not appear to share common pathwaysG Dennert, C Landon, M NowickiAdvances in Experimental Medicine and Biology|January 1, 1997
Regulation of cytotoxic T cell functions by a GPI-anchored ecto-ADP-ribosyltransferaseJ Wang, E Nemoto, G DennertJournal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated proteinJ Wang, E Nemoto, G DennertThe Journal of Experimental Medicine|March 1, 1981
Cloned cell lines with natural killer activity. Specificity, function, and cell surface markersG Dennert, G Yogeeswaran, S YamagataJournal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
Cell surface ADP-ribosyltransferase regulates lymphocyte function-associated molecule-1 (LFA-1) function in T cellsE Nemoto, Y Yu, G DennertJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1996
Release of a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase from cytotoxic T cells upon activationE Nemoto, S Stohlman, G DennertProceedings of the National Academy of Sciences of the United States of America|July 1, 1981
T cells may express multiple activities: specific allohelp, cytolysis, and delayed-type hypersensitivity are expressed by a cloned T-cell lineG Dennert, S Weiss, J F WarnerImmunopharmacology|September 1, 1993
CTX-B inhibits CTL cytotoxicity and cytoskeletal movementsS Sugawara, H R Kaslow, G DennertPageof 111